Published on in Vol 4, No 1 (2018): Jan-Jun
1 Surgery Oncology Department, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France
2 Faculté de Médecine, Université Paul Sabatier Toulouse III, Toulouse, France
3 Department of Internal Medicine, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France
4 Pôle Hospitalo-Universitaire en Cancérologie, Cancer Pharmacology of Toulouse-Oncopole and Region (Work Package 4 Research Program), Institut Universitaire du Cancer de Toulouse-Oncopole, Université Paul Sabatier Toulouse III, Toulouse, France
5 Medical and Clinical Pharmacology Unit, Centre Hospitalier Universitaire de Toulouse, Toulouse, France
6 Radiotherapy Department, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France
7 Support Care Department, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France
8 Clinical Research Department, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France
9 General Practice Department, Université Paul Sabatier Toulouse III, Toulouse, France
*these authors contributed equally